Clinical


Warning: file_get_contents(http://graph.facebook.com/?ids=http://globalpharmaupdate.com/daiichi-sankyos-enliven-phase-3-study-of-pexidartinib-met-primary-endpoint-in-tgct/): failed to open stream: HTTP request failed! HTTP/1.1 403 Forbidden in /home/globalph/public_html/wp-content/themes/delhiitsolutionsdotcom/inc/tn-counter-post.php on line 26

Warning: file_get_contents(http://graph.facebook.com/?ids=http://globalpharmaupdate.com/kura-oncology-announces-positive-phase-2-study-for-tipifarnib-in-hras-mutant-head-and-neck-cancer/): failed to open stream: HTTP request failed! HTTP/1.1 403 Forbidden in /home/globalph/public_html/wp-content/themes/delhiitsolutionsdotcom/inc/tn-counter-post.php on line 26

Warning: file_get_contents(http://graph.facebook.com/?ids=http://globalpharmaupdate.com/phase-1-clinical-trial-of-novel-clot-dissolving-therapy-ts01-completed-by-tsi/): failed to open stream: HTTP request failed! HTTP/1.1 403 Forbidden in /home/globalph/public_html/wp-content/themes/delhiitsolutionsdotcom/inc/tn-counter-post.php on line 26
share

Flex Pharma announced that, under its open investigational new drug (IND) application, the Company has initiated a Phase...

share

Ortek Therapeutics announced that the Ortek ECD™ received 510(k) clearance from the U.S. Food and Drug Administration. The ECD...

share

Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announced that the pivotal phase 3 placebo-controlled ENLIVEN (NCT02371369) study of...

share

Incyte Corporation and MedImmune, AstraZeneca’s  global biologics research and development arm, announced the expansion of their clinical collaboration....

share

Kura Oncology announced positive topline results from a Phase 2 trial for its lead product candidate, tipifarnib, in patients...

share

Thrombolytic Science, LLC (TSI) announced the completion of a Phase 1 clinical trial of TS01, a new-generation clot-dissolving...

share

MilliporeSigma announced that Celonic AG, a Swiss contract development and manufacturing organization (CDMO), is upgrading its manufacturing facility...